The declaration of nutrition, health, and intelligence for the child-to-be

Nutrition and Health

Volumn 19, Issue 1-2, 2007, Pages 85-102

  Katzen Luchenta, Jan ^a,b,c,d  

^a Association Montessori Internationale (AMI)

^b Montessori Foundation (US)

^c Mother and Child Foundation (UK)

^d AMI   (United States)

Author keywords

Brain; Children; Development; Disease; Disorder; Learning; Nutrition

Indexed keywords

ANIMALIA;

EID: 38849089314     PISSN: 02601060     EISSN: None     Source Type: Journal    
DOI: 10.1177/026010600701900212     Document Type: Conference Paper

References (168)

1. Simopoulos, A.P. (1996). Declaration of Olympia on Nutrition and Fitness. 28-29, May, Ancient Greece, Olympia.
2. Ohmi, H., Hirooka, K., Hata, A. and Mochizuki Y. (2001). Recent trend of increase in proportion of low birth weight infants in Japan. International Journal of Epidemiology, 30, 1269-1271.
3. Low Birth Weight Babies on the Rise in America's Largest Cities and Their Suburbs (2004). Journal of Urban Health, The New York Academy of Medicine, October 05.
4. Arnold, L.S. and Grad, R.K. (1992). Low birth weight and infant mortality: a health policy Perspective. NAACOGS Clin Issu Perinat Women's Health, Nurs. 1, 1-12.
5. Cockey, C.D. (2005). More babies born at very low birth weight linked to rise in infant Mortality. AWTOWN lifelines, 9, 113-114.
6. Zubrick, S.R., Kurinezuk, J.J., McDermott, B.M., Mckelvy, R.S., Silburn, S.R. and Davies, L.C. (2000). Fetal growth and subsequent mental health problems in children aged 4 to 13 years. Dev. Med. Child Neurol., 42(1), 14-20.
7. Fombonne, E., Simmons, H., Ford, T. Meltzer, H. and Goodman R. (2001). Prevalence of pervasive developmental disorders in the British nationwide survey of child mental health. J Am Acad Child Adolesc Psychiatry, 40(7), 820-7.
8. Powell, J.E., Edwards, A., Edwards, M., Pandit, B.S., Sungum-Paliwal, S.R. and Whitehouse, W. (2000). Changes in the incidence of childhood autism and other autistic spectrum disorders in preschool children from two areas of the West Midlands, UK. Dev Med Child Neurol., 42(9), 624-8.
9. House, S. (2002). Generating Healthy People. The McCarrison Society Publication, Nutrition and Health, 14(3), U.K.
10. Rees, G.A., Doyle, W., Srivastava, A., Brooke, Z.M., Crawford, M.A. and Costeloe K.L. (2005). The nutrient intakes of mothers of low birth weight babies - a comparison of Ethnic groups in East London, UK. Maternal and Child Nutrition, 1, 91-99. (Blackwell Publishing Ltd.).
11. Colver, A.F., Gibson, M., Hey, E.N., Jarvis, S.N., Mackie, P.C. and Richmond S. (2001). Increasing rates of cerebral palsy across the severity spectrum in north-east England 1964-1993, The North of England collaborative Cerebral Palsy Survey. Arch Dis Child Fetal Neonatal Ed., 83, F7-F12.
12. Cao, X.Y., Jiang, X.M., Dou, Z.H., Rakeman, M.A., Zhang, M.L., O'Donnell, K., Ma, T., Amette, K., Delong, N. and Delong G.R. (1994). Timing of vulnerability of the brain to iodine deficiency in endemic cretinism (before conception for prevention). N Engl J Med., 26, 1770-1.
13. Czeizel, A.E. and Puho, E. (2005). Maternal use of Nutritional supplementation during the first month of pregnancy and decreased risk of Down's syndrome: Case-control study. Nutrition, 6, 698-704. Discussion: 774.
14. Roth, J., Figlio, D.N., Chen, Y., Ariet, M., Carter, R.L., Resnick, M.B. and Morse S.B. (2004). Maternal and Infant Factors Associated With Excess Kindergarten Costs. PEDIATRICS, 114(3), 720-728.
15. Petrou, S., Sach, T. and Davidson L. (2001). The long-term costs of preterm birth and low Birth Weight: results of a systematic review. Child Care Health Dev., 27(2), 97-115.
16. Zito, J.M., Safer, D.J., DosReis, S., Magder, L.S., Gardner, J.F. and Zarin, D.A. (1999). Psychotherapeutic medication patterns for youths with attention - deficit/hyperactivity disorder. Arch Pediatr Adolesc Med., 153(12), 257-63. Comment: 1220-1.
17. Rushton, J.L. and Whitmire T. (2001). Pediatric Stimulant and Selective Serotonin Reuptake Inhibitor Prescription Trends, 1992 to 1998. Arch Pediatr Adolesc Med., 155, 560-565.
18. Lyon, R. (1997). National Institute of Child Health and Development, Report on Learning Disabilities Research, Testimony given before the committee on Education and the Workforce in the U.S. House of Representatives on July 10, 1997.
19. Marlow, N., D'Souza, S.W. and Chiswick, M.L. (1987). Neurodevelopmental outcome in babies weighing less than 2001 g at birth. Br Med J., 294(6587), 1582-6.
20. How "Failure to Thrive" Affects Young Brains. (2004). USDA Agriculture Research Service, Food and Nutrition Research Briefs, 2004.
21. Crawford, M.A. (1993). The role of essential fatty acids in neural development: Implications for perinatal nutrition. Am. J. Clin. Nutr., 57(suppl), 703S-710S.
22. Fattal-Valevski, A., Kesler, A., Sela, B.A., Nitzan-Kaluski, D., Rotstein, M., Mesterman, R., Toledano-Alhadef, H., Stolovitch, C., Hoffmann, C., Globus, O., Eshel, G. (2005). Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics, 115(2), 233-8.
23. Rouget, F., Monfort, C., Bahuau, M., Nelva, A., Herman, C., Francannet, C., Robert-Gnansia, E. and Cordier, S. (2005). Periconceptional folates and the prevention of orofacial clefts: role of dietary intakes in France. Rev Epidemiol Sante Publique, 53(4), 351-60.
24. Mills, J.L. and Signore, C. (2004). Neural tube defect rates before and after food fortification with folic acid. Birth Defects Res A Clin Mol Teratol., 70(11), 844-5.
25. Huhta, J.C. and Hernandez-Robles, J.A. (2005). Homocysteine, folate, and congenital heart defects. Fetal Pediatr Pathol., 24(2), 71-9.
26. Relton, C.L., Pearce, M.S., Burn, J. and Parker, L. (2005). An investigation of folate-related genetic factors in the determination of birth weight. Pediatr Perinat Epidemiol., 19(5), 360-7.
27. Del Bianco, A., Maruotti, G., Fulgieri, A.M., Celeste, T., Lombardi, L., Amato, N.A. and Pietropaolo, F. (2004). Recurrent spontaneous miscarriages and hyperhomocysteinemia. Minerva Ginecol., 56(5), 379-83. (B6 and folate restores metabolic picture and favorable pregnancy outcomes).
28. Johnson, W.G. (1999). DNA polymorphism-diet-cofactor-development hypothesis And the Gene-teratogen model for schizophrenia and other developmental disorders (B12, B6). Am J Med Genet., 88(4), 311-23.
29. Obeid, R. and Herrmann, W. (2005). Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects. Clin Chem. Lab Med., 43(10), 1052-7.
30. Ronnenberg, A.G., Goldman, M.B., Chen, D., Aitken, I.W., Willett, W.C., Selhub, J. and Xu, X. (2002). Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr., 76(6), 1385-91.
31. Cziezel, A.E. (1998). Periconceptional folic acid containing multivitamin Supplementation (B12). Eur Obstet Gynecol Reprod Biol., 78(2), 151-61.
32. Steen, M.T., Boddie, A.M., Fisher, A.J., Macmahon, W., Saxe, D., Sullivan, K.M., Dembure, P.P. and Elsas, L.J. (1998). Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenat Diagn., 18(6), 545-55.
33. Heinze, T. and Weber W. (1990). Determination of thiamine (vitamin B1) in maternal blood during normal pregnancies and pregnancies with intrauterine growth retardation. Z Emahrungswiss, 29(1), 39-46.
34. Ba, A. (2005). Functional vulnerability of developing central nervous system to maternal thiamine deficiencies in the rat. Dev Psychobiol., 47(4), 408-14.
35. Ba, A., N'Douba, V., D'Almeida, M.A. and Seri B.V. (2005). Effects of maternal thiamine deficiencies on the pyramidal and granule cells of the hippocampus of rat pups. Acta Neurobiol Exp., 65(4), 387-98.
36. Krapels, I.P., van Rooij, I.A., Ocke, M.C., van Cleef, B.A., Kuijpers-Jagtman, A.M. and Steegers-Theunissen, R.P. (2004). Maternal dietary B vitamin intake, other than folate, and the association with orofacial cleft in the offspring (thiamine and Niacin). Eur J Nutr., 43(1), 7-14.
37. Bell, L.T., Branstrator, M., Roux, C. and Hurley L.S. (1975). Chromosomal abnormalities in Maternal and fetal tissues of magnesium-or zinc-deficient rats. Teratology, 12, 221-6, Table 1.
38. Deering, S.H., Stagg, A.R., Spong, C.Y., Abubakar, K., Pezzullo, J.C. and Ghidini A. (2005). Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP). J Matern Fetal Neonatal Med., 17(2), 151-5.
39. Venu, L. Kishore, Y.D. and Raghunath, M. (2005). Maternal and perinatal magnesium restriction predisposes rat pups to insulin resistance and glucose intolerance. J Nutri., 135(60), 1353-8.
40. Iwata, H., Hayashi, T., Sato, H., Kimura, K., Kuwayama, T. and Monji Y. (2005). Modification of ovary stock solution with magnesium and raffinose improves the development competence of oocytes after long preservation. Zygote, 13(4), 303-8. (Raffinose is a complex carbohydrate found in beans and cabbage.)
41. Ghebremeskel, K., Burns, L., Burden, T.J., Harbige, L., Costeloe, K., Powell, J.J. and Crawford M. (1994). Vitamin A and related essential nutrients in cord blood: relationships with anthropometric measurements at birth (magnesium and zinc). Early Hum Dev., 39(3), 177-88.
42. Wong, W.Y., Merkus, H.M., Thomas, C.M., Menkveld, R., Zielhuis, G.A., Steegers-Theunissen, R.P. (2002). Effects of folic acid and zinc sulfate on male factor sub fertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril., 77(3), 491-8.
43. Wong, W.Y., Thomas, C.M., Merkus, J.M., Zielhuis, G.A. and Steegeers-Theunissen, R.P. (2000). Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril., 73(3), 435-42.
44. Lastra, M.D., Saldivar, L., Martinez, K., Munguia, N., Marquez, C. and Aguilar A.E. (2005). Zinc concentrations during mice gestation. Biol Trace Elem Res., 105(1-3), 205-14.
45. Scheplyagina, L.A. (2005). Impact of the mother's zinc deficiency on the woman's and newborn's health status. J Trace Elem Med Biol., 19(1), 29-35.
46. Doyle, W., Srivastava, A., Crawford, M.A., Bhatti, R., Brooke, Z. and Costloe, K.L. (2001). Inter-pregnancy folate and iron status of women in an inner-city population. Br J Nutr., 86(1), 81-7.
47. Czeizel, A.E. and Puho, E. (2005). Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study. Nutrition, 21(6), 698-704. Discussion: 774. (Folic acid and iron appear to have a preventative effect against Down's syndrome.)
48. Cao, X.Y., Jiang, X.M., Dou, Z.H., Rakeman, M.A., Zhang, M.L., O'Donnell, K., Ma, T., Amette, K., Delong, N. and Delong G.R. (1994). Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med., 331(26), 1770-1.
49. Elliot, T.C. (1987). Iodine deficiency disorders. Health Technol Dir., 7(1), 1-12.
50. Driutskaia, S.M. and Grigor'eva N.G. (2005). Iodine deficiency as a factor that diminishes the mental and intellectual development of a child. Gig Sanit, 1, 32-5.
51. Wasantwisut, E. (1997). Nutrition and development: other micronutrients' effect on growth and cognition (selenium deficiencies affects activities in brain enzymes necessary for brain development and function). Southeast Asian Trop Med Public Health, 28(Suppl 2), 78-82.
52. Jeong, D.W., Kim, E.H., Kim, T.S., Chung, Y.W., Kim, H. and Kim, I.Y. (2004). Different distributions of selenoprotein W and thioredoxin during postnatal brain development and embryogenesis. Mol Cell, 17(1), 156-9.
53. Arthur, J.R., Nicol, F., Mitchell, J.H. and Beckett, G.J. (1997). Selenium and iodine deficiencies and selenoprotein function. Biomed Environ Sci., 10(2-3), 129-35.
54. Watanabe, C. and Satoh, H. (1994). Brain selenium status and behavioral development in selenium-deficient preweanling mice. Physiol Behav., 56(5), 927-32.
55. Crawford, M.A. (1993). The role of essential fatty acids in neural development implications for perinatal nutrition. Am. J. Clin. Nutr., 57(suppl), 703S-710S.
56. Crawford, M.A., Costloe, K., Ghebremeskel, K., Phylactos, A., Skirvin, L. and Stacey F. (1997). Are deficits of arachadonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? Am J Clin Nutr., 66(4Suppl), 1032S-1041S.
57. Innis, S.M. (2003). Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr., 143(4Supp), S1-8.
58. Simopoulos, A.P. (1992). Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr., 55(3), 760-1.
59. House, S. (2002). "In the 1930's married women in Holmes Chapel in Cheshire knew that their local baker could provide them with a 'fertility loaf', 65% whole wheat and 35% wheat germ," Generating Healthy People. The McCarrison Society Publication, Nutrition and Health, 14(3), UK.
60. Wesnes, K.A., Pincock, C., Richardson, D., Helm, G. and Hails S. (2003). Breakfast reduces declines in attention and memory over the morning in school children. Appetite, 41(3), 329-331.
61. Mahoney, C.R., Taylor, H.A., Kanarek, R.B. and Samuel, P. (2005). Effect of breakfast composition on cognitive processes in elementary school children. Physiol Behav., 85(5), 635-45.
62. Thompson, H.J., Heimendinger, J., Haegele, A., Sedlacek, S.M., Gillette, C., O'Neill, C., Wolfe, P. and Conry C. (1999). Effect of increased vegetable and fruit consumption on markers of oxidative cellular damage. (12 servings a day of fruits and vegetables from a diverse number of botanical families resulted in significant reductions in markers of oxidative cellular damage to DNA and lipids.) Carcinogenesis, 20(12), 2261-6.
63. Dragsted, LO., Krath, B., Ravn-Haren, G., Vogel, U.B., Marie Vinggaard, A., Bo Jensen, P., Loft, S., Rasmussen, S.E., Sandstrom, T.L. and Pedersen A. (2006). Biological effects of fruit and vegetables. Proc Nutr Soc., 65(1), 61-7.
64. Spector, L.G., Xie, Y., Robison, L.L., Heerema, N.A., Hilden, J.M., Lange, B., Felix, C.A., Davis, S.M., Slavin, J., Potter, J.D., Blair, C.K., Reaman, G.H. and Ross J.A. (2005). Maternal Diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the Children's Oncology Group. (Mothers eating fresh fruits and vegetables had less incidence of infant leukemia.) Cancer Epidemiol Biomarkers Prev., 14(3), 651-5.
65. Suter, P.M. and Moser, C. (2005). {About fruits and vegetables: the paradise does not come back} (An increased fruit and vegetable consumption might be associated with a protection for the development of chronic diseases.) Schweiz Rundsch Med Prax., 94(44), 1723-30.
66. Knai, C., Pomerleau, J., Lock, K. and McKee, M. (2005). Getting children to eat more fruits and vegetables: a systematic review. Prev Med. {Epub ahead of print}.
67. Cockroft, J.E., Durkin, M., Masding, C. and Cade, J.E. (2005). Fruit and Vegetable intakes in a sample of pre-school children participating in the "Five for All" project in Bradford. (A greater diversity of intakes should be encouraged and these data suggest that this may be attained by increasing children's awareness by exposing them to a wider range of fruit and vegetables.) Public Health Nutri., 8(7), 861-9.
68. Hendy, H.M., Williams, K.E. and Camise TS. (2005). "Kids Choice" school lunch program increases children's fruit and vegetable acceptance. 45(3), 250-63.
69. Chapin, R.E., Robbins, W.A., Schieve, L.A., Sweeney, A.M., Tabacova, S.A. and Tomashek, K.M. (2004). Off to a good start: the influence of pre- and periconceptional (but a twinkle in the eye) exposures, parental fertility, and nutrition on children's health. Environ Health Perspect., 112(1), 68-78.
70. Zadik, Z. (2003). Maternal nutrition, fetal weight, body composition and disease in later life. J Endocrinol Invest., 26(9), 941-5.
71. Bonin, G.R., Kushi, L.H., Gallaghher, P.R., Rorke-Adams, L.B., McBride, M.L. and Cnaan, A. (2005). Maternal Diet during pregnancy and its association with Medulloblastoma in children: A children's oncology group study (French fries associated with Medulloblastoma.) Cancer Causes Control, 16(7), 877-91.
72. Pogada, J.M. and Preston-Martin, S. (2001). Maternal cured meat consumption during pregnancy and the risk of paediatric brain tumour in offspring: potentially harmful levels of intake. Public Health Nutri., 4(7), 183-9.
73. Budge, H., Gnanalingham, M.G., Gardner, D.S., Mostyn, A., Stephenson, T. and Symonds M.E. (2005). Maternal nutritional programming of fetal adipose tissue development; long-term consequences for later obesity. Birth Defects Res C Embryo Today, 75(3), 193-9.
74. Shaw, G.M., Quach, T., Nelson, V., Carmichael, S.L., Schaffer, D.M., Selvin, S. and Yang W. (2003) Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr., 78(5), 972-8.
75. Min, Y., Lowy, C., Ghebremeskel, K., Thomas, B., Offley-shore, B. and Crawford, M. (2005). Unfavorable effect of type 1 and type 2 diabetes on maternal and fetal essential fatty acid status: a potential marker of fetal insulin resistance. Am J Clin Nutr., 82(6), 1162-8.
76. Orny, A., Ratzon, N., Greenbaum, C., Wolf, A. and Dulitzky, M. (2002). School-age children born to diabetic mothers and to mothers with gestational diabetes exhibit a high rate of inattention and fine and gross motor impairment. J Pedaitr Endocrinol Metab., 14(Suppl 1), 681-9.
77. Beversdorf, D.Q., Manning, S.E., Hillier, A., Anderson, S.L., Nordgren, R.E., Walters, S.E., Nagaraja, H.N., Cooley, W.C., Gaelic, S.E. and Bauman, M.L. (2005). Timing of prenatal stressors and autism. (Changes in the cerebellum in autism are thought to correspond to an event before 30-32 weeks gestation. A higher incidence of prenatal stressors was found in autism 21-32 weeks gestation.) J Autism Dev Disord., 35(4), 471-8.
78. Wurmser, H., Rieger, M., Domogalla, C., Kahnt, A., Buchwald, J., Kowatsch, M., Kuehnert, N., Buske-Kirschbaum, A., Papousek, M., Pirke K.M. and von Voss, H. (2006). Association between life stress during pregnancy and infant crying in the first six months postpartum: A prospective longitudinal study. Early Hum Dev., Feb 9 (Epub ahead of print).
79. House, S. (2000). Primal Integration Therapy - School of Lake (the vulnerability of the fetus to all that is going on in the mother particularly in the first trimester). The International Journal of Prenatal and Perinatal Psychology and Medicine, 11(4), Journal of Prenatal and Perinatal Psychology and Health (North America) 14, 3-4.
80. Knackstedt, M.K., Hamelmann, E. and Arck, P.C. (2005). Mothers in stress: consequences for the offspring. Am J Reprod Immunol., 54(2), 63-9.
81. Innis, S.M. (2005). Essential fatty acid transfer and fetal development. (Depletion of 22:6 n-3 from the retina and brain results in reduced visual function and learning deficits.) Placenta, 26(SupplA), S70-5.
82. Neugebauer, R. (2005). Accumulating Evidence for Prenatal Nutritional Origins of Mental Disorders, JAMA. 294(5), 621-3.
83. Young, G. and Conquer, J. (2005). Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev., 45(1), 1-28. (Decreased blood levels of omega-3 fatty acids have been associated with several neuropsychiatric conditions, including Attention Deficit (Hyperactivity) Disorder, Alzheimer's disease, Schizophrenia and Depression.)
84. Richardson, A.J. (Oxon), D. Phil. (2001) Fatty Acids in Dyslexia, Dyspraxia, ADHD, and the Autistic Spectrum. The Nutrition Practitioner, (3), 18-24, 85.
85. Tanoue, Y. and Oda S. (1989). Weaning time of children with infantile autism. J Autism Dev Disord., 19(3), 425-34. (The disease developed more prevalently in the socioeconomic status where the incidence of breast-feeding was less frequent.)
86. The Unborn Child:Beginning a Whole Life and Overcoming Problems of Early Life. Roy Ridgeway: Update and expanded by Simon House: (Karnac: 2006). "Incomplete neural tube fusion 3 weeks into gestation and folate deficiency (B12 and zinc) might provoke autism. There are other genetic, emotional, and biochemical influences." Personal communication: 10.14.
87. Beversdorf, D.Q., Manning, S.E., Hillier, A., Anderson, S.L., Nordgren, R.E., Walters, S.E., Nagaraja, H.N., Cooley, W.C., Gaelic, S.E. and Bauman M.L. (2005). Timing of prenatal stressors and autism. (Changes in the cerebellum in autism are thought to correspond to an event before 30-32 weeks gestation.) Autism Dev Disord., 35(4): 471-8.
88. Rodier, P.M., Ingram, J.L., Tisdale, B., Nelson, S. and Romano, J. (1996). Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol., 370(2), 247-61.
89. Crawford, M. (2006). "Folate and B12 combine for neural protein synthesis. If deficient, the neural tube does not form properly. Deficiencies can also cause anemia and poor formation of gastro-intestinal cells. Zinc is vital to DNA transcription and protects the brain against peroxidation." Personal Communication: 12.10. (This inspired the following correlations of NTDs, autism, dyslexia, and Down's syndrome.)
90. Puskas, L.G. and Kitajka, K. (2006). Nutrigenomic Approaches to Study the Effects of N-3 PUFA Diet in the Central Nervous System. (DHA acts on multiple pathways including gene and protein activities including transcription.) Nutrition and Health, 18(3), 227-232.
91. Horvath, K. and Perman, J.A. (2002). Autism and gastrointestinal symptoms. (High prevalence of inflammation, pathologic intestinal permeability, decreased digestive enzyme activity.) Curr Gastroenterol Rep., 4(3), 251-8.
92. Grant, E. (2004). Developmental dyslexia and zinc deficiency. (Zinc deficiency impairs the function of B vitamins and blocks essential phospholipid pathways.) Lancet, 364(9430), 247-248.
93. Teplitsky, V., Huminger, D., Zoldan, J., Pitlik, S., Shohat, M. and Mittelman, M. (2003). Hereditary partial Transcobalamin 11 deficiency with neurologic, mental and hematologic abnormalities in Children and adults. (Linked to high homocysteine levels and increased frequency of neural tube defects. Early signs of hereditary partial TC11 deficiency included dyslexia Early Vitamin B12 therapy recommended for prevention) Isr Med Assoc. J., 5(12), 868-72.
94. Stein, J. (2001). The magnocellular theory of developmental dyslexia. (Sensitivity to visual motion causing "retinal slip" when reading. High amounts of PUFAs needed for membrane flexibility and conformational changes underlying magnocellular sensitivity.) Dyslexia, 7(1), 12-36.
95. Richardson, A.J., Calvin, C.M., Clisby, C., Schoenheimer, D.R., Montgomery, P., Hall, J.A., Hebb, G., Westwood, E., Talcott, J.B. and Stein, J.F. (2000). Fatty acid deficiency signs predict the severity of Reading and related difficulties in dyslexic children. Prostaglandins leukot Essent Fatty Acids, 63(1-2), 69-74.
96. Knivsberg, A.M. (1997). Urine patterns, peptide levels and IgA/IgG antibodies to food proteins in children with dyslexia. Pediatr Rehabil., 1(1), 25-33.
97. Barkai, G., Arbuzoua, S., Berkenstadt, M., Heifetz, S. and Cuckle H. (2003). Frequency of Down's syndrome and neural tube defects in the same family. Lancet, 361(9366), 1331-5. Comment: 361(9366): 1316. Comment: 362(9377): 81.
98. Yamakawa, K., Huot, Y.K., Haendelt, M.A., Hubert, R., Chen, X.N., Lyons, G.E. and Korenberg, J.R. (1998). DSCAM (Down's Syndrome Cell Adhesion Molecule): A novel member of the Immunoglobulin superfamily maps in a Down's syndrome region and is involved in the development of the nervous system. Hum Mol Genet., 7(2), 227-37.
99. Hultdin, J. (2001). Down's syndrome - should we increase homocysteine (debate)? (Disturbances of homocysteine metabolism involving B6 and B12 create a "folate trap.") Rondel, 9.
100. Fillion-Emery, N., Chango, A., Mircher, C., Barbe, F., Blehaut, H., Herbeth, B., Rosenblatt, D.S., Rethore, M.O., Lambert, D. and Nicolas, J.P. (2004). Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms. Am J Clin Nutr., 80(6), 1551-7.
101. Narchi, H. and Kulaylat, N. (1997). High incidence of Down's syndrome in infants of diabetic mothers. Arch Dis Child, 77(3), 242-4.
102. Hansson, T., Arneren, G., Sjoberg, O., Klareskoq, L. and Darnaeus A. (1999). Celiac disease in relation to immunologic serum markers, trace elements, and HLA-DR and DQ antigens in Swedish children with Down's syndrome. J. Pediatr Gastroenterol Nutr., 29(3): 286-92.
103. Bucci, I., Napolitano, G., Giuliani, C., Lio, S., Minnucci, A., Di Giacomo, F., Calabrese, G., Sabatino, G., Palka, G. and Monaco, F. (1999). Zinc sulfate supplementation improves thyroid function in hypozincemic Down's children. (Zinc deficiency has been shown to impair immune response and growth rate.) Biol Trace Elem Res., 67(3), 257-68. Comment (2000). 73(1): 93-94.
104. Ciaccio, M., Piccione, M., Giuffre, M., Macaione, V., Vocca, L., Bono, A. and Corsetto G. (2003). Amino acid profile and oxidative stress status in children affected by Down syndrome before and after supplementary nutritional treatment. (Aminoacid pathways abnormalities and defective oxidative balance are the most common metabolic problem in Down's syndrome.) Ital J Biochem., 53(2), 72-9.
105. Ross, J.A., Blair, C.K., Olshan, A.F., Robison, L.L., Smith, F.O., Heerema, N.A. and Roesler, M. (2005). Periconceptional vitamin use and leukemia risk in children with Down's syndrome. A Children's Oncology Group's Study. Cancer, 104(2), 405-10.
106. Adams, P.B., Lawson, S., Sanigorski, A. and Sinclair, A.J. (1996). Arachidonic acid to Eicosapentaenoic acid ratio in blood correlate positively with clinical symptoms of depression. Lipids, 31, 157-S161.
107. Hibbeln, J.R. (1998). Fish consumption and major depression. Lancet, 351(9110): 1213.
108. Comment: Lancet, 352(9121), 71-2.
109. Peet, M., Brind, J., Ramchard, C.N., Shah, S. and Vaukar G.K. (1998). Two double-blind placebo controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schiz Research, 49(3): 243-251.
110. Stool, A.L., Severs, W.E., Freeman, M.P., Reuters, S., Shoran, H.A., Diamond, E., Cress, K. and Tarantella L.B. (1999). Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo controlled trial. Arch Gen Psychiatry, 56(5), 407-12.
111. Bourre, J.M. (2004). Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nut Health Ageing, 8(3), 163-74.
112. Bourre, J.M. (2004). The role of nutritional factors on the structure and function of the brain: an update on dietary requirements. Rev Neurol., 160(8-9): 767-92. "Moreover, dietary omega-3 fatty acids are certainly involved in the prevention of some aspects of cardiovascular disease (including at the level of cerebral vascularization), and in some neuropsychiatric disorders, particularly depression, as well as in dementia, notably Alzheimer's disease. Vitamin B9 (folate) preserves memory during aging, and with vitamin B12 delays the onset of signs of dementia, provided it is administered in a precise clinical window, at the onset of the first symptoms."
113. Czeizel, E. and Kalina, A. (2003). Public health control of hyperhomocysteinemia and its consequences. Orv Hetil., 144(40): 1981-9. (In addition the results of intervention studies indicated a protective effect of folic acid and other B vitamins for some other congenital abnormalities, cardiovascular diseases, senile dementia and cancers.)
114. Tucker, K.L., Oiao, N., Scott, T. Rosenberg, I. and Spiro A. 3rd (2005). High homocysteine and low B vitamins predict cognitive decline in aging men: The Veterans Affairs Normative Ageing Study. Am J Clin Nutr., 82(3), 627-35.
115. Steeling, H.B. (2005). Micronutrients and Alzheimer's Disease (folate, B6, B12), Proc Nutria Soc., 64(4), 565-70.
116. Gray, G.E. (1989). Nutrition and dementia. J Am Diet Assoc., 89(12), 1795-802. "Other causes are vitamin B-12 and folate deficiencies; these are reversible dementias."
117. Gold, M., Chen, M.F. and Johnson, K. (1995). Plasma and red blood cell thiamine deficiency in patients with dementia of the Alzheimer's type. Arch Neurol., 52(11): 1081-6.
118. Landmark, K. (2006). Could intake of vitamins C and E inhibit development of Alzheimer's dementia? Tidsskr Nor Laegeforen, 126(2), 159-61.
119. Kontush, K. and Schekatolina, S. (2004). Vitamin E in neurodegenerative disorders: Alzheimer's disease. Ann N Y Acad Sci., 1031, 249-62.
120. Mecocci, P. (2004). Oxidative stress in mild cognitive impairment and Alzheimer's disease: a continuum. (Since MCI represents a condition of increased risk for AD, use of antioxidants in MCI could be of importance for prevention.) J Alzheimer's Dis., 6(2), 159-63.
121. Jayasooriya, A.P., Ackland, M.L., Mathai, M.L., Sinclair, A.J., Weisinger, R.S., Halver, J.E., Kitajka, K. and Puskas, L.G. (2005). Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood. (Neuronal zinc is involved in the formation of amyloid plaques, a major characteristic of Alzheimer's disease.) Proc Natl Acad Sci., USA, 102(20), 7133-8.
122. Foter, H.D. (1987). Disease family trees: the possible roles of iodine in goiter, cretinism, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's and Parkinson's diseases and cancers of the thyroid, nervous system and skin. Med Hypotheses, 24(3), 249-63.
123. Smorgon, C., Mari, E., Atti, A.R., Dalla Nora, E., Zamboni, P.F., Calzoni, F., Passaro, A. and Fellin R. (2004). Trace elements and cognitive impairment: an elderly cohort study. (According to these results, we may suppose that Se, Cr and Co protect cognitive function, Cu influences the evolution of cognitive impairment, while Al contributes to the pathogenesis of AD.) Arch Gerontol Geriatr., Suppl(9): 393-402.
124. Pajonk, F.G., Kessler, H., Supprian, T., Hamzei, P., Bach, D., Schweickhardt, J., Herrmann, W., Obeid, R., Simons, A., Falkai, P., Multhaup, G. and Bayer, T.A. (2005). Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimer's Dis., 8(1), 23-7.
125. Costello, R.B. and Moser-Veillon, P.B. (1992). A review of magnesium intake in the elderly. A cause for concern? Magnes Res., 5(1), 61-7.
126. Atamna, H. (2004). Heme, iron, and the mitochondrial decay of ageing. Ageing Res Rev., 3(3): 303-18.
127. Joseph, J.A., Denisova, A., Arendash, G., Gordon, M., Diamond, D., Shukitt-Hale, B. and Morgan, D. (2003). Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer's disease model. (Our data indicate for the first time that it may be possible to overcome genetic predispositions to Alzheimer's disease through diet.) Nutr Neurosci., 3, 153-62.
128. Jeandel, C., Nicolas, M.B., Dubois, F., Nabet-Belleville, F., Penin, F. and Cuny, G. (1989). Lipid peroxidation and free radical scavengers in Alzhiemer's Disease. (Vitamins C and E, selenium, and zinc deficiencies) Gerontology, 35(5-6), 275-82.
129. Schaefer, E.J., Bongard, V., Beiser, A.S., Lamon-Fava, S., Robins, S.J., Au, R., Tucker, K.L., Kyle, D.J., Wilson, P.W.F. and Wolf, P.A. (2006). Plasma Phosphatidylcholine Docosahexaenoic Acid (DHA) and the Risk of Dementia and Alzheimer's Disease. Archives of Neurology, 63, 1545-1550.
130. Nix, S.L., Mitchell, D.C. and Littman, B.J. (2005). Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cist analogs. Biochemistry, 44(11), 4458-65.
131. De Roost, N.M., Bots, M.L. and Katan M.B. (2001). Replacement of dietary saturated acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler thromb Vasc Bio., 21(7), 1233-7.
132. Carney, R.L. and Dhopeshwarkar, G.A. (1979). Trans fatty acids: positional specificity in brain lecithin. Lipids, 14(3), 257-61.
133. Dijck-Brouwer, D.A., Hadders-Algra, M., Bouwstra, H., Desci, T., Boehm, G., Martini, I.A., Boersma, E.R. and Muskiet, F.A. (2005). Lower fetal status of docosahexaenoic acid, arachidonic acid and essential fatty acids is associated with less favorable neonatal neurological condition. (c18 trans fatty acids and 18:2 omega 6 may exert negative effects by impairment of LCP status) Prostaglandins Leukot Essent Fatty Acids, 72(1), 21-8.
134. Koletzko, B. (1992). Trans fatty acids may impair biosynthesis of long-chain polyunsaturates and growth in man. (These data indicate a potential impairment of essential fatty acid metabolism and early growth by trans isomers in man, and question the safety of high dietary trans isomer intakes during pregnancy and the perinatal period.) Acta Paediatr., 81(4), 302-6.
135. Birch, E.E., Birch, D.G., Hoffman, D.R. and Uauy, R. (1992). Dietary essential fatty acid supply and visual acuity development. Investigative Ophthalmology & Visual Science, 33, 3242-3253.
136. Mamalakis, G., Tornaritis, M. and Kafatos A. (2002). Depression and adipose essential polyunsaturated fatty acids. (This is the first literature report of a relation between adipose tissue DHA and depression.) Prostaglandins Leukot Essent Fatty Acids, 67(5), 311-8.
137. Decsi, T., Borus, I., Molnar, S., Minda, H. and Veitl V. (2001). Inverse association between trans isomeric and long-chain polyunsaturated fatty acids in cord blood of full term infants. American Journal of Clinical Nutrition, 74(3): 364-68.
138. Wauben, I.P., Xing H., McCutcheon D. and Wainwright, P.E. (2001). Dietary Trans Fatty Acids Combined with a Marginal Essential Fatty Acid Status During
139. Simopoulos, A.P. (1999). Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids, 60(5-6), 421-9.
140. Simopoulos, A.P. (2000). Human requirement for N-3 polyunsaturated fatty acids (w-6 to w-3 ratio 2:1). Poult Sci., 79(7), 961-70.
141. Haag, M. (2003). Essential fatty acids and the brain. (The ratio of membrane omega-3 to omega-6 PUFAs can be modulated by dietary intake. This ratio influences neurotransmission and prostaglandin formation, processes that are vital in the maintenance of normal brain function.) Can J Psychiatry, 48(3), 195-203.
142. Fiennes, R.N.T-W., Sinclair, A.J. and Crawford M.A. (1973). Essential fatty acid studies in primates: linolenic requirements of Capuchins. (Deficiencies produced severe behavioral pathologies) J. Med. Prim., 2, 155-169.
143. Liu, J., Raine, A., Venables, P.H. and Mednick S.A. (2004). Malnutrition at age 3 years and externalizing behavior problems at ages 8, 11, and 17 years. Am J Psychiatry, 161(11), 2005-13.
144. Crawford, M. (2005). "During the day synaptic and visual activity causes the outer edges of the cells to break down: during the night they are rebuilt. It makes sense to have a good supply of DHA available during sleep." (Referred me to the work of Nicholas Bazan; DHA and rhodopsin co-migrate from the base of the cell to replace the lost sections), Personal communication: 5.18.
145. Bazan, N.G., Gordon, W.C. and Rodriquez de Turco, E.B. (1992). Docosahexaenoic acid uptake metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Adv Exp Med Biol., 318, 295-306.
146. Bazan, N.G. (2003). Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet activating factor. Journal of Lipid Research, 44, 2221-2233.
147. Itomura, M., Hamazaki, K., Sawazaki, S., Kobayashi, M., Terasawa, K., Watanabe, S. and Hamazaki, T. (2005). The effect of fish oil on physical aggression in schoolchildren-a randomized, double-blind, placebo-controlled trial. J Nutr Biochem., 16(3): 163-71.
148. Hallahan, B. and Garland, M.R. (2004). Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins Leukot Essent Fatty Acids, 71(4), 211-6.
149. Tsuda, S. et al. (2001). DNA damage induced by red food dyes orally administered to pregnant and male mice. Toxicol Sci., 61(1), 92-9.
150. Boris, M. and Mandel, F.S. (1994). Foods and additives are common causes of the attention deficit activity disorder in children. Ann Allergy, 72(5), 462-8.
151. Jones, T.W., Borg, W.P., Boulware, S.D., McCarthy, G., Sherwin, R.S. and Tamborlane W.V. (1995). Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion. J Pediar., 126(2), 171-7.
152. Goldman, J.A., Lerman, R.H., Contois, JH., Udall, J.N. Jr. (1986). Behavioral Effects of Sucrose on Preschool Children. Journal of Abnormal Child Psychology, 14(4), 565-577.
153. Wadley, G. and Martin, A. (1993). The Origins of Agriculture: A Biological Perspective; Pharmacological Properties of Cereals and Milk. Australian Biologist, 6, 96-105. Journal of the Australian College of Nutritional and Environmental Medicine, 2000, 19, 3-12.
154. Mycroft, F.J., Bhargava, H.N. and Wei, E.T. (1987). Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide. (Analogues ofMIF-1, Pro-Leu-Gly (PLG) and Tyr-Pro-Leu-Gly (YPLG), were investigated because of the possibility that they may be formed during the digestion of milk and wheat proteins in vivo.) Peptides, 8(6), 1051-5.
155. Zioudrou, C., Streaty, R.A. and Klee, W.A. (1979). Opioid Peptides Derived from Food Proteins. The Journal of Biological Chemistry, 254, 2446-2449.
156. Brantl, V., Teschemacher, H., Henschen, A. and Lottspeich, F. (1979). Novel opioid peptides derived from casein (Beta- casomorphins). Happe-Seyler's Zeitschrift fur Physiologische Chemie., 360, 1211-6. (Groups led by Zioudrou and Brantl found opioid and stimulatory activity in wheat and milk. Cereal exorphin is much stronger than bovine.)
157. Takahashi, M., Fukunaga, H., Kaneto, H., Fukudome, S. and Yoshikawa, M. (2000). Behavioral and pharmacological studies on gluten exorphin A5, a newly isolated bioactive food protein fragment in mice. Jpn J Pharmacol., 84(3), 259-65.
158. Pasi, A., Mahler, H., Lansel, N., Bernasconi, C. and Messiha, F.S. (1993). Beta-Casmorphin-immunoreactivity in the brainstem of the human infant. Res Commun Chem Pathol Pharmacol., 80(3): 305-322.
159. Olness, K. (2003). Effects on brain development leading to cognitive impairment: a worldwide epidemic. (The challenge for this century is to encourage community leaders and government officials to take on the prevention of cognitive impairment as the highest priority for society.) J Dev Behav Pediatr., 24(2), 120-30.
160. Devadas, R.P. (1976). Integrated role of nutrition in medicine-promotion of health and family planning and prevention of illness. Indian J NutrDiet, 13(11), 335-61.
161. Newnham, J.P., Moss, T.J., Nitsos, I., Sloboda, D.M. and Challis, J.R. (2002). Nutrition and the early origins of adult disease. (Prevention will be enhanced by elucidation of the mechanisms by which the fetus is programmed by the mother for the life she expects it to live.) Asia Pac J Clin Nutr., 11 Suppl(3), S537-42.
162. Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General, United States Public Health Service Office. (2001). (In the U.S., the annual economic, indirect cost of mental illnesses is estimated to be $79 billion; $63 billion in lost productivity, $12 billion in mortality costs, and $4 billion in productivity losses for incarcerated individuals and for the time of those who provide family care.)
163. European Brain Council, "127 million Europeans suffer from brain disorders; the European costs amounting to 386 billion Euros." (2005). European Brain Council Press Release, April.
164. U.S. Dept of Health and Human Services. (2003). Expenditures for health care in the United States continue to rise and are estimated to reach $1.66 trillion in 2003. National Health Expenditure Amounts and Average Percent Change by Type of Expenditure: Selected Calendar Years 1980-2012. CMS website/OACT projections.
165. Economic burden of cardiovascular diseases in the enlarged European Union. (2006). Cardiovascular disease cost the European Union's economy €169 billion in 2003. European Heart Journal, doi:10.1093/eurheartj/ ehi733.
166. Committee on Nutrition in Medical Education, Food and Nutrition Board, National Research Council, Academy of Sciences and the Institute of Medicine. (1985). Pamphlet: Nutrition Education in U.S. Medical Schools. National Academy Press, 2101 Constitution Avenue, NW, Washington DC, 20418.
167. The McCarrison Society, (urges the inclusion of nutrition as a mandatory subject in medical departments) c/o Institute of Brain Chemistry and Human Nutrition, London Metropolitan University, 166-222 Holloway Rd. London N78DB.
168. Kaput, J., Ordovas, J.M., Ferguson, L., van Ommen, B., Rodriguez, R.L., Allen, L., Ames, B.N., Dawson, K., German, B., Krauss, R., Malyj, W., Archer, M.C., Barnes, S., Bartholomew, A., Birk, R., van Bladeren, P., Bradford, K.J., Brown, K.H., Caetano, R., Castle, D., Chadwick, R., Clarke, S., Clement, K., Cooney, C.A., Corella, D., Manica da Cruz, I.B., Daniel, H., Duster, T., Ebbesson, S.O., Elliot, R., Fairweather-Tait, S., Fellon, J., Fenech, M., Finley, J.W., Fogg-Johnson, N., Gill-Garrison, R., Gibney, M.J., Gillies, P.J., Gustafsson, J.A., Hartman IV, J.L., He, L., Hwang, J.K., Jais, J.P., Jang, Y. Joost, H., Junien, C., Kanter, M., Kibbe, W.A., Koletzko, B., Korf, B.R., Kornman, K., Krempin, D.W., Langin, D., Lauren, D.R., Ho Lee, J., Leveille, G.A., Lin, S.J., Mathers, J., Mayne, M., Mcnabb, W., Milner, J.A., Morgan, P., Muller, M., Nikolsky, Y., van der Ouderaa, F., Park, T., Pensel, N., Perez-Jimenez, F., Poutanen, K., Roberts, M., Saris, W.H., Schuster, G., Shelling, A.N., Simopoulos, A.P., Southon, S., Tai, E.S., Towne, B., Trayhurn, P., Uauy, R., Visek, W.J., Warden, C., Weiss, R., Weincke, J., Winkler, J., Wolff, G.L., Zhoa-Wilson, X. and Zucker J.D. (2005). The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr., 94(5): 623-32.